
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
Professor of Preventive Cardiology, National University of Ireland, Galway Campus; Medical and Research Director, National Institute for Prevention and Cardiovascular Health; Consultant Cardiologist, University College Hospital Galway, Saolta Healthcare Group, Galway, Ireland; Adjunct Faculty, Johns Hopkins University School of Medicine, Baltimore, Maryland, USADr. J. William ("Bill") McEvoy is Professor of Preventive Cardiology at the National University of Ireland, Galway campus, and a consultant cardiologist at University College Hospital Galway. He also serves as Medical and Research Director of the National Institute for Prevention and Cardiovascular Health. Prof. McEvoy is adjunct faculty at the Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, and at the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. He serves as the ESC National Coordinator for CVD Prevention, Ireland.
Prof. McEvoy is a Fellow of the Royal College of Physicians of Ireland. With a clinical interest in the primary and secondary prevention of cardiovascular disease, Prof. McEvoy's research focuses on testing novel biomarkers of risk and clinical epidemiology, with an emphasis on hypertension and atherosclerosis. His research has resulted in numerous peer-reviewed publications, grants, and awards. He is the co-Chair of the 2024 ESC Guideline on Arterial Hypertension.
Recent Contributions to PracticeUpdate:
- AHA Scientific Sessions 2019: Recommendations From Dr. J. William McEvoy
- Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction
- Early-Life Environmental Exposures Impact Blood Pressure in Children
- ESC 2019: Recommendations From Dr. J. William McEvoy
- Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes
- Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes
- Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
- The Rise and Fall of Aspirin in the Primary Prevention of Cardiovascular Disease
- BP Management in Specific Populations
- Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes